Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 12/20 | 0.55 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.55 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4267775 | 0.98 | GGPS1 (0.59) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL9486308 | 0.98 | GGPS1 (0.59) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL4267687 | 0.98 | FDPS (0.53) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL9487614 | 0.96 | GGPS1 (0.57) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL9067976 | 0.94 | FDPS (0.52) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL4095717 | 0.87 | FDPS (0.53) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL10902877 | 0.86 | FDPS (0.48) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL11299591 | 0.85 | FDPS (0.44) | FDPSGGPS1 | |
| SCHEMBL11688737 | 0.82 | FDPS (0.50) | FDPSGGPS1SMPD1 | |
| SCHEMBL11109156 | 0.82 | GGPS1 (0.48) | FDPSGGPS1SMPD1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140248317-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | GLYTECH, INC. (JP) | 2014-09-04 | — | — | US | disclosed |
| EP-2567963-A1 | Trehalose compound, method for producing same, and pharmaceutical product containing the compound | Otsuka Chemical Co., Ltd. (JP) | 2013-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140248317-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | TREH, MAN2B1, NFATC1 | FDPS 3111/4885GGPS1 1666/4885SMPD1 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.